Antidepressant discontinuation syndrome

About 20% of patients develop antidepressant discontinuation syndrome following an abrupt stoppage of or marked reduction in the dose of an antidepressant taken continuously for one month.[1][1] Symptoms are usually mild and may occur following treatment with any type of antidepressant. Symptoms

• Publication year

  2017

• Venue

  Canadian Medical Association Journal

• Publication date

  2017-05-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1503/cmaj.160991PMID 28554948PMCID PMC5449237
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review

  2015cited by this paper
• Guidance for the Discontinuation or Switching of Antidepressant Therapies in Adults

  2013cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders

  2013cited by this paper
• Antidepressant discontinuation syndrome.

  2006cited by this paper
• FINISH: remembering the discontinuation syndrome. Flu-like symptoms, Insomnia, Nausea, Imbalance, Sensory disturbances, and Hyperarousal (anxiety/agitation)

  1998cited by this paper

• Cytochrome P450 2D6 (CYP2D6) Inhibition by Bergamottin and Diosmetin as a Strategy to Enhance the Pharmacokinetics and Antidepressant Efficacy of Amoxapine

  2026cites this paper
• The short-term effectiveness of antidepressants in a transdiagnostic sample and determinants of side effects and medication nonadherence: an observational study

  2026influential citation
• Protracted escitalopram discontinuation syndrome and serotonin toxicity associated with CYP2C19 poor metabolism: A case report

  2026cites this paper
• Translating Basic Science to Clinical Applications: A Narrative Review of Repurposed Pharmacological Agents in Preclinical Models of Diabetic Neuropathy

  2025cites this paper
• Clinical Implications of Antidepressants and Associated Risk of Bleeding: A Narrative Review

  2025cites this paper
• A Review of Neonatal Selective Serotonin Reuptake Inhibitor Withdrawal Syndrome.

  2025cites this paper
• Discontinuing antidepressant medication: a qualitative evidence synthesis and logic model based on health professionals’ views

  2025cites this paper
• The psychedelic-peptide paradox: a hormetic hypothesis

  2025cites this paper
• Benzodiazepine Withdrawal Symptom Clusters: Distinct Phenotypes with Treatment Implications

  2025cites this paper
• Antidepressant Use and Withdrawal

  2025cites this paper
• Interactions between psilocybin, LSD, and serotonergic antidepressants: A qualitative analysis of user reports

  2025cites this paper
• From the Gut to the Brain: Potential Novel Avenues for IBD Treatment Via Serotonergic Pathways.

  2025cites this paper
• Comparative Real-World Safety Profiles of Six Selective Serotonin Reuptake Inhibitors: A Global Pharmacovigilance Analysis

  2025cites this paper
• Examining Antidepressant Discontinuation Syndrome (ADS) Among Hospice Patients in the Last Week of Life.

  2025cites this paper
• A rare case of antidepressant discontinuation syndrome triggered by domperidone: Clinical insights and literature review

  2025cites this paper
• Five-Year Trends in SSRI Consumption: A Precision Medicine Approach to Comparative Analysis Between Serbia and European Countries

  2025cites this paper
• Assessment of Potential Factors Influencing Attention-Deficit/Hyperactivity Disorder Drug Adherence: A Database Study

  2025cites this paper
• Serotonergic antidepressants are associated with increased acute bleeding events following femur fracture fixation: A nationwide matched cohort analysis of 5,477 patients.

  2025cites this paper
• Genetic and Regulatory Mechanisms of Comorbidity of Anxiety, Depression and ADHD: A GWAS Meta-Meta-Analysis Through the Lens of a System Biological and Pharmacogenomic Perspective in 18.5 M Subjects

  2025cites this paper
• The Association Between Selective Serotonin Reuptake Inhibitors and the Incidence of Delirium in Critically Ill Patients: A Systematic Review

  2025cites this paper
• Empty bottles, rising risks: A case-crossover study on psychotherapeutic medication depletion and suicide triggers.

  2025cites this paper
• Hidradenitis Suppurativa Symptom Relief: Pain and Itch.

  2025cites this paper
• Preoperative use of serotonergic antidepressants is associated with increased rates of complications and surgical revision in autologous breast reconstruction.

  2025cites this paper
• Alternate-day dosing to taper antidepressants risks severe withdrawal effects: an in silico analysis.

  2025cites this paper
• Rebound effect, discontinuation, and withdrawal syndromes associated with drugs used in psychiatric and neurological disorders

  2024cites this paper
• Differential bioconcentration and sensitivity of Dreissena polymorpha and Dreissena rostriformis bugensis to the antidepressant sertraline.

  2024cites this paper
• Impact of Antidepressant use on Intraoperative Blood Loss and Transfusion Rates in Lumbar Fusion Surgery.

  2024cites this paper
• Exploring Patient-Generated Annotations to Digital Clinical Symptom Measures for Patient-Centered Communication

  2024cites this paper
• A REVERSE PHASE ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY-PHOTO DIODE ARRAY ESTIMATION OF CAPTOPRIL AND HYDROCHLOROTHIAZIDE IN BULK AND PHARMACEUTICAL DOSAGE FORM

  2024cites this paper
• Prolonged Discontinuation Syndrome of Venlafaxine: A Case Study of Severe Gastrointestinal Manifestations

  2024cites this paper
• Psychodynamic psychotherapy for gender dysphoria is not conversion therapy.

  2024cites this paper
• First manic episode induced by abrupt discontinuation of sertraline in a patient with OCD: A case report

  2024cites this paper
• Psychopharmacological treatment in patients planned for hip or knee replacement

  2024cites this paper
• Central Neuromodulators in Irritable Bowel Syndrome: Why, How, and When

  2024cites this paper
• Comprehension and usefulness of Spanish language health information about depression treatment.

  2024cites this paper
• Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression

  2024cites this paper
• Environmentally benign first derivative synchronous spectrofluorimetry for the analysis of two binary mixtures containing duloxetine with avanafil or tadalafil in spiked plasma samples.

  2024cites this paper
• Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects

  2024cites this paper
• The lived experience of withdrawal from Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants: A qualitative interview study

  2024cites this paper
• Discontinuation of antidepressant treatment: a retrospective cohort study on more than 20,000 participants

  2023cites this paper
• Proposed Recommendations for the Management of Depression in Adults with Epilepsy: An Expert Consensus

  2023cites this paper
• On-Chip Electromembrane Surrounded Solid Phase Microextraction for Determination of Tricyclic Antidepressants from Biological Fluids Using Poly(3,4-ethylenedioxythiophene)—Graphene Oxide Nanocomposite as a Fiber Coating

  2023cites this paper
• Atypical Withdrawal Symptoms after Abrupt Tramadol Discontinuation: A Case Report

  2023cites this paper
• Teacher-Related Factors and their Influence on the Integration of Practical Skills in Teaching and Learning of Agriculture in Secondary Schools in Busia County, Kenya

  2023cites this paper
• Mechanism of Antidepressant Action of (2R,6R)-6-Hydroxynorketamine (HNK) and Its Compounds: Insights from Proteomic Analysis

  2023cites this paper
• Transient global amnesia following abrupt discontinuation of escitalopram.

  2023cites this paper
• Ovarian Gene Transcriptional Responses To Antidepressant Drugs (Imipramine And Fluoxetine) In Female Wistar Rats

  2023cites this paper
• Antidepressant discontinuation and the role of the pharmacist

  2023cites this paper
• Impact of Abrupt Interruption of Home Psychotropic Medications at ICU Admission

  2023cites this paper
• Do discontinuation symptoms predict depression relapse after antidepressant cessation?

  2023cites this paper
• Recent Progress in Gels for Neuropathic Pain

  2023cites this paper
• Pharmacotherapy for Depression and Anxiety in the Primary Care Setting

  2023cites this paper
• Major depressive disorder

  2023cites this paper
• Role of the Intestinal Microbiota in the Genesis of Major Depression and the Response to Antidepressant Drug Therapy: A Narrative Review

  2023cites this paper
• The Effects of Competition on Physician Prescribing

  2023cites this paper
• Designing Flexible Longitudinal Regimens: Supporting Clinician Planning for Discontinuation of Psychiatric Drugs

  2022cites this paper
• Transitions in depression: if, how, and when depressive symptoms return during and after discontinuing antidepressants

  2022cites this paper
• Antidepressant discontinuation syndrome: A state-of-the-art clinical review.

  2022cites this paper
• The Efficacy of S-Adenosyl Methionine and Probiotic Supplementation on Depression: A Synergistic Approach

  2022cites this paper
• Treatment of depression in the first primary care consultation: A qualitative study

  2022cites this paper
• Short-course antidepressant therapy reduces discontinuation syndrome while maintaining treatment efficacy in patients with refractory functional dyspepsia: A randomized controlled trial

  2022cites this paper
• Effect of selective serotonin reuptake inhibitor discontinuation on anxiety-like behaviours in mice

  2022cites this paper
• Physical Activity and Diet as a Perceived Panacea to Mental Illness of Women in India: Reality Check

  2022cites this paper
• Medical Treatment of Disorders of Ejaculation.

  2022cites this paper
• Hyperbolic dose reduction of escitalopram mitigates withdrawal syndrome: a case report

  2022cites this paper
• Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) Venlafaxine, Desvenlafaxine, Duloxetine, Milnacipran, Levomilnacipran

  2022cites this paper
• Effect of Forest Therapy on Depression and Anxiety: A Systematic Review and Meta-Analysis

  2021cites this paper
• Depression in patients with CKD and ESRD

  2021cites this paper
• What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications

  2021cites this paper
• A case report on elderly psychotic-like symptoms caused by antidepressant discontinuation

  2021cites this paper
• Antidepressants Produce Persistent Gαs-Associated Signaling Changes in Lipid Rafts after Drug Withdrawal

  2021influential citation
• Withdrawal Symptoms Following Discontinuation of Vortioxetine—Retrospective Chart Review

  2021influential citation
• Residual symptoms in bipolar disorders: Findings from the bipolar Disorder course and outcome study from India (BiD-CoIN study).

  2021cites this paper
• The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Menopausal Hot Flashes: A Systematic Review of Clinical Trials

  2021cites this paper
• Effect of SSRI discontinuation on anxiety-like behaviours in mice

  2021cites this paper
• It’s all About the Meds

  2021cites this paper
• The Economic Impact of Depression Treatment in India

  2021cites this paper
• Understanding Delivery of Collectively Built Protocols in an Online Health Community for Discontinuation of Psychiatric Drugs

  2021cites this paper
• Serotonin Reuptake Inhibitors: Citalopram, Escitalopram, Fluoxetine, Fluvoxamine, Paroxetine, and Sertraline

  2021cites this paper
• The neural substrates of different depression symptoms: Animal and human studies

  2021cites this paper
• Neuromodulators in the Brain-Gut Axis: their Role in the Therapy of the Irritable Bowel Syndrome.

  2021cites this paper
• Trazodone and Depression

  2021cites this paper
• Post-Traumatic Stress Disorder Management in a Patient while Undergoing Fracture Shaft Femur Surgery

  2021cites this paper
• Employment effects of healthcare policy: Evidence from the 2007 FDA black box warning on antidepressants.

  2020cites this paper
• Tramadol Withdrawal in the Setting of Buprenorphine Induction: A Case Report.

  2020cites this paper
• Patient Safety: Aggression, Irritability, and Violence: Drug-induced Behaviors

  2020cites this paper
• Consequences of a Missed History: A Case of Antidepressant Discontinuation Syndrome

  2020cites this paper
• Vortioxetine versus other antidepressants in the treatment of Burning Mouth Syndrome: an open-label randomized trial.

  2020cites this paper
• General practitioners’ and psychiatrists’ attitudes towards antidepressant withdrawal

  2020cites this paper
• Pharmacological Treatments for Patients with Treatment-Resistant Depression

  2020cites this paper
• Effects of antidepressant medicines on preventing relapse of unipolar depression: a pooled analysis of parametric survival curves

  2020cites this paper
• Psychotropic drugs in dermatology: A dermatologist's approach and choice of medications

  2020cites this paper
• United Nations Security Council Resolutions

  2020cites this paper
• Antidepressants: Indications, Contraindications, Interactions, and Side Effects

  2020cites this paper
• Managing bipolar disorder during pregnancy and the postpartum period: a critical review of current practice

  2020cites this paper
• Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database

  2020cites this paper
• Antidepressant Discontinuation Syndrome: A Common but Underappreciated Clinical Problem

  2020cites this paper
• Development of Obsessive-Compulsive Symptoms Following Abrupt Discontinuation of Venlafaxine

  2020cites this paper
• A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based?

  2019cites this paper
• Tapering of SSRI treatment to mitigate withdrawal symptoms.

  2019cites this paper